“In a mouse study, administering 12.6 g/L (150 mM) of bicarbonate (baking soda) in drinking water enhanced performance on visual function tests (optomotor response and visual evoked potentials) in mice with oxidative stress-induced visual impairment (paraquat-induced, used as a glaucoma model), via activation of the enzyme soluble…”
Plain restatementA peer-reviewed mouse experiment reported that sodium bicarbonate added to drinking water at 150 mM preserved two measures of visual function in mice given paraquat to induce oxidative stress, with the authors attributing the effect to activation of soluble adenylyl cyclase. The post additionally implies this supports using household baking soda to improve human vision.
The study behind this post is real. Researchers at UC San Diego published it in the journal Antioxidants in June 2024, and the figure in the post is genuinely from that paper. In it, mice were given drinking water containing sodium bicarbonate for a week, then poisoned with paraquat to cause oxidative stress, and the bicarbonate group held up better on two vision tests than the mice given paraquat alone. That part of the claim is accurate. What is misleading is the packaging: this was prevention against a chemical poison in about nine mice per group, not a treatment that improved anyone's eyesight, and there is no human study of drinking baking soda for vision or glaucoma. The mouse dose also scales to a large daily amount of baking soda and sodium for a person, far above normal dietary sodium guidance. Paraquat poisoning is also not a true glaucoma model, and one of the two vision measures showed no significant change. Anyone reading this as a reason to drink baking soda for their eyes is going well beyond what the study shows.
[drifted from the evidence:] In a mouse [drifted from the evidence:] study, administering 12.6 g/L (150 mM) of bicarbonate [drifted from the evidence:] (baking soda) in drinking water [drifted from the evidence:] enhanced performance on visual function [drifted from the evidence:] tests (optomotor response and visual evoked potentials) in mice [drifted from the evidence:] with oxidative [drifted from the evidence:] stress-induced visual impairment (paraquat-induced, used as a glaucoma model), via activation of [drifted from the evidence:] the enzyme soluble adenylyl cyclase [drifted from the evidence:] (sAC)" plus post [drifted from the evidence:] caption: "natural ways to improve vision," [drifted from the evidence:] "Absolutely wild the things it can do," presented alongside an Arm & Hammer baking soda box.
A [added by the neutral restatement:] peer-reviewed mouse [added by the neutral restatement:] experiment reported that sodium bicarbonate [added by the neutral restatement:] added to drinking water [added by the neutral restatement:] at 150 mM preserved two measures of visual function in mice [added by the neutral restatement:] given paraquat to induce oxidative [added by the neutral restatement:] stress, with the authors attributing the effect to activation of soluble adenylyl cyclase. [added by the neutral restatement:] The post [added by the neutral restatement:] additionally implies this supports using household baking soda to improve [added by the neutral restatement:] human vision.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- The study is real, peer reviewed, and from an established academic glaucoma research group.
- The figure shown is the paper's genuine Figure 2 and the caption is quoted accurately.
- The dose stated (150 mM, 12.6 g/L in drinking water) matches the paper and the conversion is arithmetically correct.
- Bicarbonate did improve optomotor response and VEP P1-N1 amplitude in paraquat-treated mice relative to paraquat alone.
- The four bullet points in the post's caption (RGC protection, reduced glial activation, increased mitochondrial biogenesis, increased ATP production) are all reported findings of the paper in mice.
- Bicarbonate is a genuine physiological sAC activator, so the proposed mechanism is biologically plausible and is the authors' own stated interpretation.
- Species extrapolation and marketing framing: pairing the figure with a retail Arm & Hammer box and an offer of help with "natural ways to improve vision" invites readers to treat a mouse pretreatment experiment as a consumer vision remedy. No human evidence for this use exists.
- Omitted qualifier (prevention, not restoration of existing loss): bicarbonate was started one week before the toxin and continued through it. The design tests protection against an acute chemical insult, not recovery of pre-existing or age-related visual impairment. The claim's phrase "in mice with oxidative stress-induced visual impairment" reads as treatment of an existing condition.
- Omitted qualifier (no baseline improvement shown): nothing in the study supports vision being improved in healthy animals. "Absolutely wild the things it can do" generalises a protective effect in poisoned mice into a general capability.
- Imprecise model description: paraquat is a systemic oxidative stress inducer, not an intraocular pressure based glaucoma model. The paper frames its relevance to glaucomatous neurodegeneration mechanisms and used a separate ischemic injury model for the pressure-related arm. Calling the paraquat arm "a glaucoma model" overstates its specificity.
- Omitted qualifier (partial result): the VEP latency measure did not reach statistical significance. The post presents an unqualified success.
- Dose context removed: the mouse exposure corresponds to a large daily sodium bicarbonate intake in human terms, well above ordinary dietary sodium guidance. A reader is left with no sense of what dose the finding rests on.
- Commercial incentive: the post ends in a newsletter capture and a paid consultation funnel, which is relevant to how the evidence is being framed.
- Whether the in vivo visual function benefit was confirmed as sAC-dependent through a knockout or inhibitor control. Not established from the text retrieved.
- Effect magnitude and whether visual function was fully or only partially normalised. Exact numeric values from the figure panels were not retrievable in text form.
- Whether any benefit would occur without a paraquat-style oxidative insult. Not tested in the way the post implies.
- Human relevance at any dose. No human trial of oral bicarbonate for visual function or glaucoma was found across multiple search strategies.
- My human-equivalent dose estimate depends on assumed mouse water intake and allometric scaling and should be treated as approximate.
The study exists, is peer reviewed, is open access, and the figure in the post is its genuine Figure 2. The figure caption text in the post matches the published caption verbatim. The paper reports: mice were given regular drinking water or drinking water containing 150 mM NaHCO3 for one week before treatment with paraquat (15 mg/kg), an oxidative stress inducer, and under oxidative stress the researchers observed a decline in visual acuity indicated by reduced spatial frequency and reduced visual evoked potential P1-N1 amplitudes, along with increased latency, measured by optomotor response and VEP . Bicarbonate administration restored spatial frequency and VEP P1-N1 potentials in the oxidatively stressed mice, although there were no statistically significant differences in latency . The broader findings the post lists in its caption are also in the paper: using mouse models of oxidative stress induced by ischemic injury and paraquat administration, the authors found that administration of bicarbonate, as an activator of sAC, protected retinal ganglion cells, blocked AMP-activated protein kinase activation, inhibited glial activation, and improved visual function . The paper further reports that bicarbonate ameliorated mitochondrial dysfunction in RGCs by enhancing mitochondrial biogenesis, preserving mitochondrial structure, and increasing ATP production . No human study of ingested bicarbonate for vision, visual acuity, or glaucoma was found. The largest randomised human trial of oral sodium bicarbonate located (a different clinical question, kidney disease) found no significant treatment effect on the primary physical function outcome, no significant benefit on any secondary outcome, and more frequent adverse events in the bicarbonate arm (457 vs 400) , with the authors concluding oral sodium bicarbonate did not improve physical function or renal function, increased adverse events, and is unlikely to be cost-effective for that patient group .
Complete reasoning
The reply receipt is formatted for pasting into the thread where the claim is circulating.
Compact share page: verify.trueseeker.com/s/46d84f7e414a/nfzUEI9dpxb-yqTJw9q7X7G